In the last trading session, 49.61 million shares of the Hims & Hers Health Inc (NYSE:HIMS) were traded, and its beta was 1.61. Most recently the company’s share price was $34.75, and it changed around $1.88 or 5.72% from the last close, which brings the market valuation of the company to $7.72B. HIMS currently trades at a discount to its 52-week high of $72.98, offering almost -110.01% off that amount. The share price’s 52-week low was $11.20, which indicates that the current value has risen by an impressive 67.77% since then. We note from Hims & Hers Health Inc’s average daily trading volume that its 10-day average is 22.78 million shares, with the 3-month average coming to 20.85 million.
Hims & Hers Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.47. If we narrow it down even further, the data shows that 1 out of 16 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 8 recommended HIMS as a Hold, whereas 4 deemed it a Buy, and 1 rated it as Underweight. Hims & Hers Health Inc is expected to report earnings per share of 0.21 for the current quarter.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS has showed a green trend with a performance of 5.72% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 35.69 on recent trading dayincreased the stock’s daily price by 2.63%. The company’s shares are currently up 43.71% year-to-date, but still up 4.86% over the last five days. On the other hand, Hims & Hers Health Inc (NYSE:HIMS) is -47.67% down in the 30-day period. We can see from the shorts that 51.84 million shares have been sold at a short interest cover period of 1.68 day(s).
The consensus price target as assigned by Wall Street analysts is $25.5, which translates to bulls needing to decrease their stock price by -36.27% from its current value. Analyst projections state that HIMS is forecast to be at a low of $21 and a high of $68.
Hims & Hers Health Inc (HIMS) estimates and forecasts
The year-over-year growth rate is expected to be 57.93%, up from the previous year.
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of 535.21M in revenue for the current quarter. 11 analysts expect Hims & Hers Health Inc to make 564.91M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 278.17M and 315.65M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 92.40%. Forecasts for the next quarter put sales growth at 78.97%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.22%. Hims & Hers Health Inc earnings are expected to increase by 12.77% in 2025, but the outlook is positive 31.05% per year for the next five years.
HIMS Dividends
Hims & Hers Health Inc’s next quarterly earnings report is expected to be released on 2025-Feb-23.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 11.28% of Hims & Hers Health Inc shares, and 79.06% of them are in the hands of institutional investors. The stock currently has a share float of 89.11%. Hims & Hers Health Inc stock is held by 535.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 7.7166% of the shares, which is about 16.47 million shares worth $332.55 million.
BLACKROCK INC., with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Core S&P Small-Cap ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 12.29 shares worth $426.91 million, making up 5.75% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 5.27 shares worth around $183.2 million, which represents about 2.47% of the total shares outstanding.
